A case of brain infarction during cisplatin-based combined chemotherapy with bleomycin, etoposide and cisplatin for testicular cancer

Japanese Journal of Urology

Volumn 100, Issue 1, 2009, Pages 12-15

  Osawa, Takahiro ^a   Sugishita, Keiji ^a   Murakumo, Masashi ^a   Koyanagi, Tomohiko ^a  

^a KUSHIRO ROSAI HOSPITAL   (Japan)

Author keywords

Brain infarction; Chemotherapy; Testicular cancer

Indexed keywords

EID: 60549117695     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol.100.12     Document Type: Article

References (22)

1. Bosl GJ. Motzer RJ: Testicular germ-cell cancer. N. Engl.J. Med., 337, 242-253, 1997.
2. Chaudhary UB, Haldas JR: Long-term complications of chemotherapy for germ cell tumours. Drugs, 63, 1565-1577, 2003.
3. Cohen RJ, Cuneo RA, Cruciger MP, Jackman AE: Transient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin. J. Clin. Oncol., 1, 392-393, 1983.
4. Lederman GS, Garnick MB: Pulmonary emboli as a complication of germ cell cancer treatment. J. Urol., 137, 1236-1237, 1987.
5. Hall MR, Richards MA, Harper PG: Thromboembolic events during combination chemotherapy for germ cell malignancy. Lancet, 2, 1259, 1988.
6. Icli F, Karaoguz H, Dincol D, Demirkazik A, Gunel N, Karaoguz R, Uner A: Severe vascular toxicity associated with cisplatin-based chemotherapy. Cancer, 72, 587-593, 1993.
7. Doll DC, List AF, Greco FA, Hainsworth JD, Hande KR, Johnson DH: Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis. Ann. Intern. Med., 105, 48-51, 1986.
8. Cantwell BM, Mannix KA, Roberts JT, Ghani SE, Harris AL: Thromboembolic events during combination chemotherapy for germ cell-malignancy. Lancet, 2, 1086-1087, 1988.
9. Stefenelli T, Kuzmits R, Ulrich W, Glogar D: Acute vascular toxicity after combination chemo-therapy with cisplatin, vinblastine, and bleomycin for testicular cancer. Eur. Heart J., 9, 552-556, 1988.
10. Weijl NI, Rutten MF, Zwinderman AH, Keizer HJ, Nooy MA, Rosendaal FR, Cleton FJ, Osanto S: Thromboembolic events during chemotherapy for germ cell cancer, a cohort study and review of the literature. J. Clin. OncoL, 18, 2169-2178, 2000.
11. Shoji S, Miyakita H, Shima M, Usui Y, Nagata Y, Uchida T, Terachi T: Acute myocardial infarction during combined chemotherapy with bleomycin, etoposide and cisplatin for testicular cancer. Hinyokika Kiyo, 52, 723-726, 2006.
12. Japanese source
13. Edwards RL, Silver J, Rickles FR: Human tumor procoagulants, registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis. Thromb. Haemost, 69, 205-213, 1993.
14. Gordon SG, Mielicki WP: Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue. Blood Coagul. Fibrinolysis, 8, 73-86, 1997.
15. Hara Y, Steiner M, Baldini MG: Characterization of the platelet-aggregating activity of tumor cells. Cancer Res., 40, 1217-1222, 1980.
16. Pearlstein E, Salk PL, Yogeeswaran G, Karpatkin S: Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line. Proc. Natl. Acad. Sci. USA, 77, 4336-4339, 1980.
17. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA Jr: Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium, characterization and comparison with the actions of interleukin 1. Proc. Natl. Acad. Sci. USA, 83, 4533-4537, 1986.
18. Nawroth PP, Stern DM: Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J. Exp. Med., 163, 740-745, 1986.
19. Licciardello JT, Moake JL, Rudy CK, Karp DD, Hong WK: Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology, 42, 296-300, 1985.
20. Lajer H, Daugaard G: Cisplatin and hypomagnesemia. Cancer Treat Rev., 25, 47-58, 1999.
21. Turlapaty PD, Altura BM: Magnesium deficiency produces spasms of coronary arteries, relationship to etiology of sudden death ischemic heart disease. Science, 208, 198-200, 1980.
22. Piketty AC, Flechon A, Laplanche A, Nouyrigat E, Droz JP, Theodore C, Fizazi K: The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area. Br. J. Cancer, 93, 909-914, 2005.